Login / Signup

Radiobiological evaluation considering the treatment time with stereotactic radiosurgery for brain metastases.

Hisashi NakanoTakeshi TakizawaDaisuke KawaharaSatoshi TanabeSatoru UtsunomiyaMotoki KaiduKatsuya MaruyamaShigekazu TakeuchiKiyoshi OndaMasahiko KoizumiTeiji NishioHiroyuki Ishikawa
Published in: BJR open (2022)
There has been no published investigation of the radiobiological impact of the longer treatment time with multiple interruptions of SRS using a CK on the target dose distribution in a comparison with the use of a linac. Radiobiological dose assessment that takes into account treatment time in the physical dose in this study may allow more accurate dose assessment in SRS for metastatic brain tumors using CK.
Keyphrases
  • small cell lung cancer
  • squamous cell carcinoma
  • randomized controlled trial
  • protein kinase
  • replacement therapy